Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Metronomic topotecan impedes tumor growth ofMYCN-amplified neuroblastoma cellsin vitroandin vivoby therapy induced senescence

9 Dec 2015

Abstract excerpt

// Sabine Taschner-Mandl 1 , Magdalena Schwarz 1 , Johanna Blaha 1 , Maximilian Kauer 1 , Florian Kromp 1 , Nelli Frank 1 , Fikret Rifatbegovic 1 , Tamara Weiss 1 , Ruth Ladenstein 1, 2 , Martin Hohenegger 3 , Inge M. Ambros 1 , Peter F. Ambros 1, 2 1 CCRI, Chlidren's Cancer Research Institute, Vienna, Austria 2 Department of Pediatrics, Medical University of Vienna, Vienna, Austria 3 Center for Physiology and...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer, Hypoxia, and Metabolism
Share to Cell death mechanisms and regulation
Share to Neuroblastoma Research and Treatments

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 26657295
DOI: 10.18632/oncotarget.6527

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Metronomic topotecan impedes tumor growth ofMYCN-amplified neuroblastoma cellsin vitroandin vivoby therapy induced senescencePMID 26657295Read ↗

Senescence in neural cell lines: comparative insights from SH-SY5Y and ReNcell VMSemantic proximity Read ↗

A multi-omics integrative approach unravels novel genes and pathways associated with senescence escape after targeted therapy in NRAS mutant melanomaSemantic proximity Read ↗

Novel senolytic and senescence-suppressing compounds overcome senescence-driven chemoresistance in NSCLCSemantic proximity Read ↗

Convergence of therapy-induced senescence (TIS) and EMT in multistep carcinogenesis: current opinions and emerging perspectivesSemantic proximity Read ↗

A multi-omics integrative approach unravels novel genes and pathways associated with senescence escape after targeted therapy in NRAS mutant melanomaSemantic proximity Read ↗

Tumour-derived extracellular vesicles within the therapy-induced senescent secretome distinctly suppress breast cancer via DKK1-mediated inflammatory responseSemantic proximity Read ↗

Targeting aurora kinases limits tumour growth through DNA damage‐mediated senescence and blockade of NF‐κB impairs this drug‐induced senescenceSemantic proximity Read ↗

Therapy-Induced Tumor Cell Senescence: Mechanisms and Circumvention.Semantic proximity Read ↗

Therapy-induced senescence in breast cancer: an overviewSemantic proximity Read ↗

Senescence-Induced Chemoresistance in Triple Negative Breast Cancer and Evolution-Based Treatment StrategiesSemantic proximity Read ↗

Induction of Cellular Senescence by Doxorubicin Is Associated with Upregulated miR-375 and Induction of Autophagy in K562 CellsSemantic proximity Read ↗

A multi-stage process including transient polyploidization and EMT precedes the emergence of chemoresistent ovarian carcinoma cells with a dedifferentiated and pro-inflammatory secretory phenotypeSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.